美国鼻咽癌:就诊时分期中的种族与民族差异
基于美国国家癌症数据库(NCDB)2004-2021年15,862例鼻咽癌患者,采用多因素有序逻辑回归分析就诊时IV期疾病的种族差异,发现苗裔、老挝裔、非夏威夷太平洋岛民和黑人患者IV期比例较高,中国患者较低。
要点
- 苗裔(73.2%)、老挝裔(61.5%)、其他太平洋岛民(60.9%)和黑人(50.0%)患者IV期比例较高。
- 中国患者IV期比例为35.7%,调整后OR为0.72(p<0.001)。
- 需要提高对非典型受累群体的鼻咽癌认识。
核心结论
- 尽管大多数鼻咽癌患者为中国人、白人或黑人,但就诊时IV期疾病在苗裔、老挝裔、非夏威夷太平洋岛民和黑人患者中最常见。
研究设计与样本
- 回顾性队列研究,使用美国国家癌症数据库(NCDB)2004-2021年数据,共纳入15,862例鼻咽癌患者,采用多因素有序逻辑回归调整人口学和社会经济因素。
主要发现
- 在15,862例患者中,11,173例(70.4%)为男性,中位年龄59岁;10,034例(63.3%)为白人,2,272例(14.3%)为黑人,1,103例(7.0%)为中国人,442例(2.8%)为菲律宾人,338例(2.1%)为越南人。
- disaggregation前,IV期疾病比例:白人43.2%(参照),黑人50.0%(aOR 1.12,p=0.012),美洲原住民52.0%(aOR 1.18,p>0.05),亚裔美国人41.9%(aOR 0.97,p>0.05),夏威夷原住民及其他太平洋岛民55.1%(aOR 1.47,p=0.021)。
- disaggregation后,IV期疾病比例:黑人50.0%(aOR 1.12,p=0.012),老挝裔61.5%(aOR 2.21,p=0.001),苗裔73.2%(aOR 2.92,p<0.001),其他太平洋岛民60.9%(aOR 1.83,p=0.004),菲律宾裔44.2%(aOR 1.21,p=0.033)。
- 中国患者IV期比例为35.7%(aOR 0.72,p<0.001)。
临床怎么用
- 作者认为需要努力提高对非典型受累群体(苗裔、老挝裔、非夏威夷太平洋岛民和黑人)的鼻咽癌认识。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Although nasopharynx cancer (NPC) is rare in the United States, global epidemiology varies greatly. Therefore, understanding NPC disparities in the diverse US setting is critical. METHODS AND MATERIALS: Data from the National Cancer Database (NCDB, 2004-2021) identified patients with NPC; NCDB allows disaggregation by Asian American (AA) subgroups. Multivariable ordinal logistic regression adjusting for demographic and socioeconomic factors defined adjusted odds ratios (aORs). RESULTS: Of 15,862 patients, 11,173 (70.4%) were male (median age 59). Commonest groups included 10,034 (63.3%) White, 2,272 (14.3%) Black, 1,103 (7.0%) Chinese, 442 (2.8%) Filipino, and 338 (2.1%) Vietnamese patients. Prior to disaggregation, the proportion of stage IV disease at presentation was 43.2% among White (ref), 50.0% among Black (aOR 1.12, p = 0.012), 52.0% among Native American (aOR 1.18, p > 0.05), 41.9% among AA (aOR 0.97, p > 0.05), and 55.1% among Native Hawaiian and Other Pacific Islander patients (aOR 1.47, p = 0.021). Upon disaggregation, the proportion of stage IV disease was the greatest (>50%) among Black (50.0%, aOR 1.12, p = 0.012), Laotian (61.5%, aOR 2.21, p = 0.001), Hmong (73.2%, aOR 2.92, p < 0.001), and Other Pacific Islander patients (60.9%, aOR 1.83, p = 0.004); 44.2% of Filipino patients also presented with stage IV disease (aOR 1.21, p = 0.033). Odds of presenting with advanced stage disease were lower among Chinese patients (35.7% stage IV, aOR 0.72, p < 0.001). CONCLUSIONS: Although most NPC patients were Chinese, White, or Black, stage IV disease at presentation was most common among Hmong, Laotian, non-Hawaiian Pacific Islander, and Black patients. Efforts are needed to improve awareness of NPC among less canonically affected groups. LEVEL OF EVIDENCE: 4 Laryngoscope, 135:1113-1119, 2025.
引用
- Dee EC, Wang S, Ho FDV, et al. Nasopharynx Cancer in the United States: Racial and Ethnic Disparities in Stage at Presentation. Laryngoscope. 2024. PMID: 39548864. doi:10.1002/lary.31907
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。